Patent · US Active

Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability

US7994130B2 · kind B2 · utility

1Cited by
252References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 11, 2007
Grant dateAug 9, 2011
Priority date
Expiry dateDec 11, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/164
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds, compositions and methods for inhibiting vascular permeability and pathologic angiogenesis are described herein. Methods for producing and screening compounds and compositions capable of inhibiting vascular permeability and pathologic angiogenesis are also described herein. Pharmaceutical compositions are included in the compositions described herein. The compositions described herein are useful in, for example, methods of inhibiting vascular permeability and pathologic angiogenesis, including methods of inhibiting vascular permeability and pathologic angiogenesis induced by specific angiogenic, permeability and inflammatory factors, such as, for example VEGF, bFGF and thrombin. Methods for treating specific diseases and conditions are also provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.